October 31, 2019
Apple's high on health. Apple CEO Tim Cook was pleased as punch with his company’s latest quarterly and yearly report, which he said on an investor’s call yesterday was Apple’s “highest revenue in a September quarter ever” at $64 billion. Thirty-three million dollars of this was in iPhone revenue — a 9% decline over last year that he felt was a significant step up from the 15% decline seen...
July 25, 2019
Healthcare artificial intelligence company Viz.ai announced that it is joining forces with Medtronic with the goal of speeding up adoption of the former’s technology. Specifically the pair will be working on getting Viz.ai’s system, which specializes on stroke detection, into more stroke treatment centers in the US.
“Medtronic is an innovative company focused on therapies that extend life and...
June 10, 2019
On Friday, the American Diabetes Association kicked off its annual conference in San Francisco, where academics, vendors and other stakeholders congregated to unveil new study results and major announcements related to diabetes management. And while MobiHealthNews already put together a roundup featuring an opening salvo of the show’s announcements, the past few days have seen a tidal wave of new...
May 28, 2019
Aggregated real-world outcome data collected from thousands of Medtronic MiniMed 670G users indicate that patients on the system spend an average 71% of their time within an optimal glycemic range.
Collected from nearly 8 million days of recorded system use and announced by Medtronic today in a press release, the new findings also suggest that this rate increased further for those who employed...
January 3, 2019
Sugar.IQ — the digital diabetes assistant for Guardian Connect system users that is jointly supported by Medtronic and IBM Watson — has a new feature that uses artificial intelligence to predict future low glucose events.
Called IQcast, the feature tells users whether they have a low, medium or high chance of dropping below the target blood glucose range within the next one to four hours. These...
December 18, 2018
The FDA has approved an app-based smart programming device used to discreetly and easily control implants treating for overactive bladder (OAB), chronic fecal incontinence (FI) and non-obstructive urinary retention, medical device maker Medtronic announced yesterday.
Called the InterStim smart programmer and designed for use with Medtronic’s InterStim system, the product consists of a Samsung...
November 21, 2018
Medtronic has announced that it will acquire long-time partner Nutrino, an AI powered personalized nutrition platform for an undisclosed sum.
As part of the deal Medtronic will be integrating Nutrino’s AI-driven personalized insights and food database. The acquisition is set to specifically boost Medtronic’s offerings for people living with diabetes and offer the company’s predictive glycemic...
August 16, 2018
A recent study published in JAMA Surgery found that when it comes to reporting conflicts of interest in regards to compensation from medical device companies, doctors aren’t always completely forthcoming.
Researchers discovered that only 37.3 percent of publications written by a sample of doctors receiving the greatest compensation from device companies declared all relevant conflicts of...
July 18, 2018
Israel is continuing to carve out its space as a digital health hub in the Middle East. Today the Israeli government announced a $33 million grant aimed at furthering the country's foothold in digital health, specifically in biotech and medicine, according to Reuters. Medtronic, GE Healthcare, and Change Healthcare were named the three recipients of the funding; each company will get a different...
July 11, 2018
In 2016, UnitedHealthcare and Medtronic cut a deal that established the latter’s devices as the preferred insulin pumps for United members with diabetes. Now, the companies have announced year one data suggesting that members who took advantage of the companies’ arrangement experienced fewer preventable hospital admissions when compared to members relying on multiple daily injections of insulin...